Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 388

1.

A Dose Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis.

Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, Mc Hugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE.

Am J Respir Crit Care Med. 2015 Feb 5. [Epub ahead of print]

PMID:
25654354
[PubMed - as supplied by publisher]
2.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Dec;94(6):701-7.

PMID:
25621361
[PubMed - in process]
3.

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.

Cambau E, Viveiros M, Machado D, Raskine L, Ritter C, Tortoli E, Matthys V, Hoffner S, Richter E, Perez Del Molino ML, Cirillo DM, van Soolingen D, Böttger EC.

J Antimicrob Chemother. 2015 Mar;70(3):686-96. doi: 10.1093/jac/dku438. Epub 2014 Nov 11.

PMID:
25587993
[PubMed - in process]
4.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, Ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Oct 13. pii: S1472-9792(14)20507-5. doi: 10.1016/j.tube.2014.09.002. [Epub ahead of print]

PMID:
25423883
[PubMed - as supplied by publisher]
5.

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.

Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW.

J Antimicrob Chemother. 2015 Mar;70(3):811-7. doi: 10.1093/jac/dku431. Epub 2014 Oct 25.

PMID:
25344808
[PubMed - in process]
6.

Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure.

den Hertog AL, Menting S, van Soolingen D, Anthony RM.

Emerg Infect Dis. 2014 Nov;20(11):1932-3. doi: 10.3201/eid2011.130560. No abstract available.

PMID:
25340553
[PubMed - in process]
Free PMC Article
7.

Identification of a novel conjugative plasmid in mycobacteria that requires both type IV and type VII secretion.

Ummels R, Abdallah AM, Kuiper V, Aâjoud A, Sparrius M, Naeem R, Spaink HP, van Soolingen D, Pain A, Bitter W.

MBio. 2014 Sep 23;5(5):e01744-14. doi: 10.1128/mBio.01744-14.

PMID:
25249284
[PubMed - in process]
Free PMC Article
8.

Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.

van Soolingen D, Wisselink HJ, Lumb R, Anthony R, van der Zanden A, Gilpin C.

Int J Tuberc Lung Dis. 2014 Aug;18(8):885-9. doi: 10.5588/ijtld.13.0629.

PMID:
25199000
[PubMed - in process]
9.

Molecular epidemiology of tuberculosis in Cambodian children.

Schopfer K, Rieder HL, Steinlin-Schopfer JF, van Soolingen D, Bodmer T, Chantana Y, Studer P, Laurent D, Zwahlen M, Richner B.

Epidemiol Infect. 2014 Jul 22:1-12. [Epub ahead of print]

PMID:
25050615
[PubMed - as supplied by publisher]
10.

Disclosure of selective advantages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics.

de Keijzer J, de Haas PE, de Ru AH, van Veelen PA, van Soolingen D.

Mol Cell Proteomics. 2014 Oct;13(10):2632-45. doi: 10.1074/mcp.M114.038380. Epub 2014 Jul 14.

PMID:
25022876
[PubMed - in process]
11.

Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates.

Sengstake S, Bablishvili N, Schuitema A, Bzekalava N, Abadia E, de Beer J, Tadumadze N, Akhalaia M, Tuin K, Tukvadze N, Aspindzelashvili R, Bachiyska E, Panaiotov S, Sola C, van Soolingen D, Klatser P, Anthony R, Bergval I.

BMC Genomics. 2014 Jul 7;15:572. doi: 10.1186/1471-2164-15-572.

PMID:
25001491
[PubMed - in process]
Free PMC Article
12.

Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex.

de Beer JL, Ködmön C, van Ingen J, Supply P, van Soolingen D; Global Network for Molecular Surveillance of Tuberculosis 2010.

Int J Tuberc Lung Dis. 2014 May;18(5):594-600. doi: 10.5588/ijtld.13.0531.

PMID:
24903798
[PubMed - indexed for MEDLINE]
13.

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.

Simons SO, van der Laan T, Mulder A, van Ingen J, Rigouts L, Dekhuijzen PN, Boeree MJ, van Soolingen D.

Clin Microbiol Infect. 2014 Oct;20(10):1015-20. doi: 10.1111/1469-0691.12696. Epub 2014 Jul 16.

PMID:
24890253
[PubMed - in process]
14.

A novel approach - the propensity to propagate (PTP) method for controlling for host factors in studying the transmission of Mycobacterium tuberculosis.

Nebenzahl-Guimaraes H, Borgdorff MW, Murray MB, van Soolingen D.

PLoS One. 2014 May 21;9(5):e97816. doi: 10.1371/journal.pone.0097816. eCollection 2014.

PMID:
24849817
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands.

de Zwaan R, van Ingen J, van Soolingen D.

J Clin Microbiol. 2014 Jul;52(7):2544-51. doi: 10.1128/JCM.00233-14. Epub 2014 May 7.

PMID:
24808238
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis.

Bolhuis MS, van der Laan T, Kosterink JG, van der Werf TS, van Soolingen D, Alffenaar JW.

Eur Respir J. 2014 Sep;44(3):808-11. doi: 10.1183/09031936.00041314. Epub 2014 May 2. No abstract available.

PMID:
24791826
[PubMed - in process]
17.

Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological marker.

van Soolingen D.

Lancet Respir Med. 2014 Apr;2(4):251-2. doi: 10.1016/S2213-2600(14)70049-9. Epub 2014 Mar 4. No abstract available.

PMID:
24717616
[PubMed - indexed for MEDLINE]
Free Article
18.

Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011.

Ruesen C, van Gageldonk-Lafeber AB, de Vries G, Erkens CG, van Rest J, Korthals Altes H, de Neeling H, Kamst M, van Soolingen D.

Euro Surveill. 2014 Mar 20;19(11). pii: 20738.

PMID:
24679720
[PubMed - indexed for MEDLINE]
Free Article
19.

Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011.

De Beer JL, Kodmon C, van der Werf MJ, van Ingen J, van Soolingen D; ECDC MDR-TB Molecular Surveillance Project Participants.

Euro Surveill. 2014 Mar 20;19(11). pii: 20742.

PMID:
24679719
[PubMed - indexed for MEDLINE]
Free Article
20.

Inventory study of non-tuberculous mycobacteria in the European Union.

van der Werf MJ, Ködmön C, Katalinić-Janković V, Kummik T, Soini H, Richter E, Papaventsis D, Tortoli E, Perrin M, van Soolingen D, Zolnir-Dovč M, Ostergaard Thomsen V.

BMC Infect Dis. 2014 Feb 6;14:62. doi: 10.1186/1471-2334-14-62.

PMID:
24502462
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk